Shyh-Han Tan is a prominent inventor based in Kensington, MD (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on monoclonal antibodies and cancer cell detection methods. With a total of 3 patents, Tan's inventions are paving the way for advancements in cancer diagnosis and treatment.

Latest Patents

Tan's latest patents include groundbreaking developments in monoclonal antibodies that specifically bind to ERG. These antibodies can be utilized in various forms, including non-human and humanized monoclonal antibodies. His work provides methods for detecting ERG and fusion proteins in clinical settings, which is crucial for diagnosing malignancies associated with ERG overexpression, such as prostate cancer and acute myeloid leukemia. Additionally, he has developed methods for isolating and detecting cancer cells in biological fluids, particularly urine, which is vital for early cancer diagnosis and prognosis.

Career Highlights

Shyh-Han Tan is affiliated with The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. His work has been instrumental in advancing the understanding of cancer biology and improving diagnostic techniques. His innovative approaches have garnered attention in the scientific community and have the potential to impact patient care significantly.

Collaborations

Tan collaborates with esteemed colleagues, including Shiv Srivastava and Albert Dobi. These partnerships enhance the research efforts and contribute to the development of effective cancer therapies.

Conclusion

Shyh-Han Tan's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His innovative approaches are set to make a lasting impact on cancer diagnosis and treatment.

This text is generated by artificial intelligence and may not be accurate.